Sanofi Pharma Bristol-Myers Squibb SNC | diagnosia.com

Sanofi Pharma Bristol-Myers Squibb SNC

Address: -
Telephone: -
Fax: -
Web: -
Email: -
Corporate Phone: -

For Pharmacy Companies

Get your Diagnosia.com profile and a presence on europe's leading medical drug search.

Logo Upload your logo
Contact details Your full contact details
Branding Let your CI do the talking
Newsfeed Integrate your corporate news

More Information

Drugs produced by Sanofi Pharma Bristol-Myers Squibb SNC

Aprovel 150 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 150 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 300 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 300 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 75 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Aprovel 75 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Clopidogrel Winthrop 300 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: B01AC04
- Active Substance: Clopidogrel
Clopidogrel Winthrop 75 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: B01AC04
- Active Substance: Clopidogrel
CoAprovel 150 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
CoAprovel 150 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
CoAprovel 300 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
CoAprovel 300 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
CoAprovel 300 mg/25 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
DuoPlavin 75 mg/100 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: B01AC30
- Active Substance: Clopidogrel
DuoPlavin 75 mg/75 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: B01AC30
- Active Substance: Clopidogrel
Irbesartan Hydrochlorothiazide Winthrop 150 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 150 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 300 mg/12.5 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 300 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Hydrochlorothiazide Winthrop 300 mg/25 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
Irbesartan Winthrop 150 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Irbesartan Winthrop 150 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Irbesartan Winthrop 300 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Irbesartan Winthrop 300 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Irbesartan Winthrop 75 mg film-coated tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
Irbesartan Winthrop 75 mg tablets
- admission:
  Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan

Pages